Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

571 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population.
Plaquevent M, Tétart F, Fardet L, Ingen-Housz-Oro S, Valeyrie-Allanore L, Bernard P, Hebert V, Roussel A, Avenel-Audran M, Chaby G, D'Incan M, Ferrier-Le-Bouedec MC, Duvert-Lehembre S, Picard-Dahan C, Jeudy G, Collet E, Labeille B, Morice C, Richard MA, Bourgault-Villada I, Litrowski N, Bara C, Mahe E, Prost-Squarcioni C, Alexandre M, Quereux G, Bernier C, Soria A, Thomas-Beaulieu D, Pauwels C, Dereure O, Benichou J, Joly P; French Investigators for Skin Adverse Reaction to Drugs; French Study Group on Autoimmune Bullous Skin Diseases. Plaquevent M, et al. Among authors: roussel a. J Invest Dermatol. 2019 Apr;139(4):835-841. doi: 10.1016/j.jid.2018.10.045. Epub 2018 Dec 10. J Invest Dermatol. 2019. PMID: 30543900 Free article.
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg-1 per day starting dose of oral corticosteroids to treat bullous pemphigoid.
Hébert V, Bastos S, Drenovska K, Meijer J, Ingen-Housz-Oro S, Bedane C, Lunardon L, Debarbieux S, Jedlickova H, Caux F, Chaby G, D'Incan M, Feliciani C, Boulard C, Schumacher N, Schmidt E, Roussel A, Richard MA, Gottlieb J, Ferranti V, Guérin O, Bénichou J, Joly P; French study group on autoimmune bullous skin diseases, and the autoimmune bullous skin disease task force of the European Academy of Dermatology and Venereology. Hébert V, et al. Among authors: roussel a. Br J Dermatol. 2021 Dec;185(6):1232-1239. doi: 10.1111/bjd.20593. Epub 2021 Sep 2. Br J Dermatol. 2021. PMID: 34173243
Clinical and immunological features and outcome of anti-p200 pemphigoid.
Commin MH, Schmidt E, Duvert-Lehembre S, Lasek A, Morice C, Estival JL, Debarbieux S, Rigal E, Pauwels C, De Quatrebarbes J, Roussel A, Goujon E, Stoebner PE, Jouen F, Joly P. Commin MH, et al. Among authors: roussel a. Br J Dermatol. 2016 Oct;175(4):776-81. doi: 10.1111/bjd.14629. Epub 2016 Aug 24. Br J Dermatol. 2016. PMID: 27037896
Recurrence of drug-induced reactions in DRESS patients.
Picard D, Vellar M, Janela B, Roussel A, Joly P, Musette P. Picard D, et al. Among authors: roussel a. J Eur Acad Dermatol Venereol. 2015 Apr;29(4):801-4. doi: 10.1111/jdv.12419. Epub 2014 Mar 13. J Eur Acad Dermatol Venereol. 2015. PMID: 24628777
Biological Therapies or Apremilast in the Treatment of Psoriasis in Patients with a History of Hematologic Malignancy: Results from a Retrospective Study in 21 Patients.
Cohen-Sors R, Fougerousse AC, Reguiai Z, Maccari F, Mahé E, Delaunay J, Roussel A, de la Breteque MA, Cottencin C, Bertolotti A, Kemp H, Chaby G. Cohen-Sors R, et al. Among authors: roussel a. Clin Cosmet Investig Dermatol. 2021 Jul 8;14:845-854. doi: 10.2147/CCID.S320098. eCollection 2021. Clin Cosmet Investig Dermatol. 2021. PMID: 34267533 Free PMC article.
[Interstitial pneumonia after infliximab therapy for psoriasis].
Leger S, Etienne M, Duval-Modeste AB, Roussel A, Caron F, Thiberville L. Leger S, et al. Among authors: roussel a. Ann Dermatol Venereol. 2011 Jun-Jul;138(6-7):499-503. doi: 10.1016/j.annder.2011.01.043. Epub 2011 Mar 21. Ann Dermatol Venereol. 2011. PMID: 21700071 French.
571 results